Investigations of TF, FTL, PCBP1 and VDAC3 and their different specificities in terms of their roles in iron metabolism, independent of lipid-lowering treatment actions, may also be of high interest in the treatment of iron overload and deficiency. This evidence concerns the gene PCBP1 and hyperinsulinemic hypoglycemia, familial, 4.